NCT06378398 2026-03-13
A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
Clinical Trials
10 trialsNCT02950259 2025-12-03
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Providence Health & Services
Phase 1 Completed
NCT05680870 2025-09-09
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
Tanta University
Phase 3 Completed
NCT02595372 2021-12-15
Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy
Indiana University
Phase 2 Completed
NCT04154748 2019-11-19
Argon Plasma Coagulation for Barrett's Esophagus
Maria Sklodowska-Curie National Research Institute of Oncology
Phase NA Completed
NCT01566474 2019-09-13
Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study
Aragon Institute of Health Sciences
Phase 3 Completed
NCT00002682 2018-10-24
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00201422 2016-03-28
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma
National Health Research Institutes, Taiwan
Phase NA Completed
NCT01093755 2016-03-17
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
Mayo Clinic
Phase 4 Completed
NCT01465113 2016-03-10
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed